Clinical features of familial hypercholesterolemia in a Mediterranean population;Manifestaciones clínicas de la hipercolesterolemia familiar en una población Mediterránea

Medicina Clinica

Volumn 113, Issue 14, 1999, Pages 521-525

  Alonso Villaverde, Carlos ^d   Sardà, Pilar ^e   Vallbé, Joan Carles ^e   Heras, Mercedes ^e   Pérez Jiménez, Francisco ^a   Pedro Botet, Joan Carlos ^b   Ros Rahola, Emilio ^c   Masana, Lluís ^e  

^a Hospital Universitario Reina Sofia Cordoba   (Argentina)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e NONE

Author keywords

Corneal arch; Familial hypercholesterolemia; Ischaemic cardiophaty; Mediterranean diet; Risk factors; Xanthelasmas; Xanthomas

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ADULT; ARTICLE; BLOOD; FEMALE; GENETICS; GENOTYPE; HEALTH SURVEY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SOUTHERN EUROPE;

ADULT; APOLIPOPROTEINS E; CHOLESTEROL; FEMALE; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MEDITERRANEAN REGION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033619303     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hobs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-446.
2. Goldstein JL, Brown MS. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci USA 1973; 70: 2.804-2.808.
3. Brown MS, Golstein JL. Expresion of the familial hypercholesterolemia gene in heterozygotes: mechanism for dominant disorder in man. Science 1974; 135: 61-53.
4. Khachadurian AK. The inheritance of essential familial hypercholesterolemia. Am J Med 1964; 37: 400-407.
5. Khachadurian AK, Uthman SM. Experiences with homozygous cases of familial hypercholesterolemia. A report of 52 patients. Nutr Metab 1973; 15: 132-140.
6. Goldstein JL, Scarott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1.544-1.568.
7. Thompson GR, Seed M, Niththyananthan S, McCarthy S, Thorogood M. Genotypic and phenotypic variation in familial hypercholesterolemia. Arteriosclerosis 1989; 9 (Supl 1): 75-80.
8. Streja D, Steines G, Kwiterovich PO Jr. Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia. Ann Intern Med 1978; 89: 871-880.
9. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH et al. Diagnosis heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993; 72: 171-176.
10. Hsia SH, Connelly PW, Hegele RA. Genetic diagnosis of familial hypercholesterolemia in affected relatives using pedigree tracing. Clin Biochem 1996; 4: 371-377.
11. Álvarez-Sala LA, Mata P, Garrido JA, Montoya MT, Blázquez E, Gómez Gerique JA et al. Xantomas en la hipercolesterolemia familiar heterozigota del adulto. ¿Son un hallazgo frecuente en España? Clin Invest Arteriosclerosis 1997; 9: 135-142.
12. Gudnason V, King-Underwood M, Seed X, Sun A, Soutar A, Humphries H. Identification of recurrent and novel mutation in Exon 4 of the LDL receptor gene in patients with familial hypercholesterolemia in the United Kingdom. Arterioscler Thromb 1993; 13: 56-63.
13. Hansen PS, Rüdiger N, Tybjaerg-Hansen A, Faergeman O, Gregersen N. Detection of the apoB-3500 (glutamine for arginine) by gene amplification and cleavage with Mspl. J Lipid Res 1991; 32: 1.229-1.233.
14. Hixson JE, Vermier DT. Restriction isotyping. of human apolipoprotein E by gene amplification and cleaveage with Hhal. J Lipid Res 1990; 31: 545-548.
15. Albers II, Adolphson JI, Hazzard WR. Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18: 331-338.
16. Beaumont V, Jacoctot B, Beaumont J-L. Ischaemic disease in men and women with familial hypercholesterolemia and xanthomatosis. A comparative study of genetic and enviromental factors in 274 heterozygous cases. Atherosclerosis 1976; 24: 441-450.
17. Mabuchi H, Haba T, Ueda K, Ueda R, Tatami R, Ito S et al. Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan. Atherosclerosis 1977; 28: 417-423.
18. Gagne C, Moorjani S, Brun D, Toussaint M, Lupien P-J. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoprotein, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis 1979; 34: 13-24.
19. Yamamoto A, Kamiya T, Yamamura T, Yokoyama S, Horiguchi Y, Funahashi T et al. Clinical features of familial hypercholesterolemia. Arteriosclerosis 1989; 9 (Supl 1): 66-74.
20. Shepherd J, Packard CJ. Lipoprotein metabolism in familial hypercholesterolemia. Arteriosclerosis 1989; 9 (Supl 1): 39-42.
21. Real JT, Romero G, Priego MA, Chaves FJ, Ascaso JF, Carmena R. Hipercolesterolemia familiar y niveles plasmáticos de Lp(a): Dos factores de riesgo cardiovascular. An Med Intern 1999; 16: 69-72.
22. Falcó C, Estellés A, Dalmau J, España F, Aznar J. Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity study in families with high lipoprotein (a) levels. Thromb Haemost 1998; 79: 818-823(A).
23. Civeira F, Castillo JJ, Calvo C, Ferrando J, De Pedro C, Martínez-Rodes P et al. Tamaño del tendón de Aquiles por ecografía de alla resolución en población sana. Med Clin (Barc) 1998; 111: 56-57.
24. Chambless LE, Fuchs FD, Linn S, Kritchevsky SB, Larosa JC, Segal P et al. The association of corneal arcus with coronary heart disease and cardiovascular disease mortality in the Lipid Research Clinics Mortality Follow-up Study. Am J Public Health 1990; 80: 1.200-1.204.
25. Plans P, Pardell H, Salleras L. Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993; 4: 381-389.
26. Postiglione A, Nappi A, Brunetti A, Soricelli A, Rubba P, Gnasso A et al. Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia. Atherosclerosis 1991; 90: 23-30.
27. Jensen J, Blankenhorn DH, Kornerup V. Coronary disease in familial hypercholesterolemia. Circulation 1967; 36: 77-82.
28. Stone NJ, Levy RI, Fredrichkson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 1974; 49: 476-488.
29. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson G, Boerwinkle E. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) level: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci USA 1989; 86: 4.171-4.174.
30. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
31. Real JT, Chaves JF, Martínez-Uso I, Ascaso JF, Armengod ME, Carmena R. Detección de la primera familia portadora de la mutación R3500Q del gen de apo B responsable del defecto familiar de apo B 100 [resumen]. Clin Invest Arteriosclerosis 1998; 10: 61.
32. Adroer R, Santacruz P, Blesa R, López-Pousa S, Ascaso C, Oliva R. Apoliprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosciencie Letters 1995; 189: 1-5.
33. Hahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
34. Ward AJ, Okane M, Nicholls DP, Young IS, Nevin NC, Graham CA. Novel single base deletion in the LDLR gene (211delG). Effects on serum lipids profiles and the influence of other genetic polymorphism in the ACE, Apo A and Apo B genes. Atherosclerosis 1996; 120: 83-91.
35. Rosenman RH, Brand RJ, Sholtz IR, Jenkins CD. Relation of corneal arcus to cardiovascular risk factors and the incidence of coronary disease. N Engl J Med 1974; 291: 1.322-1.324.